5th Annual Global Pharmacovigilance & Risk Management Summit
15th - 17th of June 2021
Dr Avinash Kakade
Lupin
“Outsourcing of PV activities and it’s oversight”
ABOUT THE INTERVIEW
Prior to our “5th Annual Global Pharmacovigilance & Risk Management Summit”, the chairperson Mircea Ciuca from CSL Behring, held an exclusive interview with one of the speakers Dr. Avinash Kakade from Lupin Global.
Dr Avinash R Kakade is currently the Global Head of Pharmacovigilance at Lupin Limited. He is responsible for global pharmacovigilance and medical information activities at Lupin. Prior to Lupin, he was in a similar role at Cipla Limited. Being a Medical Doctor, he practiced for 6 years in community and hospitals before starting his career in pharmaceutical industry. He has worked with Wockhardt, Sciformix, Aspen, Accenture and Amgen in the past.
What can the participants expect from your presentation, can you summarize the most exciting part of it?
What do you think will be the biggest topic in PharmacoVigilance world in 2021?
What are the top 3 changes you expect to see in PV in the near future?
Dr. Kakade will be speaking on Day 2 of the conference!
Outsourcing of PV activities and it’s oversight
- PV Outsourcing – Past Present and Future
- Challenges in outsourcing
- Oversight of outsourcing
Do you feel you will benefit?
For registration details and group discounts, please contact:
Adrian Best
Adrian.Best@marxosmith.com
About The Speaker
Dr Avinash R Kakade is currently the Global Head of Pharmacovigilance at Lupin Limited. He is responsible for global pharmacovigilance and medical information activities at Lupin. Prior to Lupin, he was in a similar role at Cipla Limited. Being a Medical Doctor, he practiced for 6 years in community and hospitals before starting his career in pharmaceutical industry. He has worked with Wockhardt, Sciformix, Aspen, Accenture and Amgen in the past.
He is a certified PMP from PMI and has Lean Six Sigma Black Belt certification along with a Masters in Biostatistics. He loves cooking which acts as a stress buster for him. He is associated with a journal of pharmacovigilance and drug research in a pro bono advisory member role.
Disclaimer:
The views, information, or opinions expressed during this interview for the 5th Annual Global Pharmacovigilance & Risk Management Summit are solely those of the individuals involved and do not necessarily represent LUPIN and its employees.